Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This clinical trial will evaluate the combination of quaratusugene ozeplasmid with atezolizumab as maintenance therapy for patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC). The study is comprised of 2 phases, a dose selection phase (Phase 1) and a safety and efficacy evaluation phase (Phase 2).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Potwierdzony zaawansowany rak płuca małokomórkowy (przed rozpoczęciem pierwszego leczenia)
- •Dobra odpowiedź na wstępne chemioterapię (trzeba trzech lub czterech cykli leczenia)
- •Dobry stan ogólny (zdolność do codziennych czynności)
- •Wyleczyły się czy zagoiły rany po dużych operacjach (co najmniej 28 dni temu)
- •Przerzuty do mózgu muszą być nieobjawowe i stabilne (co najmniej 21 dni po leczeniu)
- •Wystarczająca liczba krwinek i trombocytów
- •Prawidłowa funkcja nerek, wątroby i serca
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- September 11, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (17)
Rocky Mountain Cancer Centers, LLP
Lone Tree, United States
Washington University School of Medicine - Siteman Cancer Center
St Louis, United States
Gabrail Cancer Center Research
Canton, United States
Oncology_Hematology Care Clinical Trials, LLC
Cincinnati, United States
Oncology_Hematology Care Clinical Trials, LLC
Cincinnati, United States
Oncology_Hematology Care Clinical Trials, LLC
Cincinnati, United States
Oncology_Hematology Care Clinical Trials, LLC
Cincinnati, United States
Oncology_Hematology Care Clinical Trials, LLC
Fairfield, United States
Willamette Valley Cancer Institute (Oregon)
Eugene, United States
Northwest Cancer Specialists, P.C.
Portland, United States
Providence Cancer Institute
Portland, United States
Northwest Cancer Specialists, P.C.
Portland, United States
Northwest Cancer Specialists, P.C.
Tigard, United States
Texas Oncology - DFW
Dallas, United States
Texas Oncology - Northeast Texas
Tyler, United States
Virginia Cancer Specialists, PC
Fairfax, United States
Northwest Cancer Specialists, P.C.
Vancouver, United States
Trial contact
Sr Director, Clinical Operations
Chief Medical Officer
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/12/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.